Scarica l'app Stockscreener
81.52
0.09%
0.3997
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LNTH Giù?
Forum
Previsione
Precedente Chiudi:
$81.92
Aprire:
$81.33
Volume 24 ore:
47,540
Relative Volume:
0.05
Capitalizzazione di mercato:
$5.70B
Reddito:
$1.50B
Utile/perdita netta:
$427.61M
Rapporto P/E:
13.56
EPS:
6.01
Flusso di cassa netto:
$423.98M
1 W Prestazione:
-9.34%
1M Prestazione:
-14.49%
6M Prestazione:
-15.18%
1 anno Prestazione:
+44.99%
Intervallo 1D:
$81.20
$83.82
Intervallo di 1 settimana:
$81.20
$93.27
Portata 52W:
$54.69
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Nome
Lantheus Holdings Inc
Settore
Telefono
978 671-8001
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Confronta LNTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
81.48 | 5.70B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
172.34 | 78.63B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.7201 | 44.54B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.21 | 42.61B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.23 | 18.79B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
127.73 | 13.55B | 612.78M | -86.37M | -62.91M | -0.87 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-18 | Iniziato | Goldman | Buy |
| 2024-09-03 | Iniziato | Redburn Atlantic | Buy |
| 2024-07-10 | Reiterato | JMP Securities | Mkt Outperform |
| 2023-12-18 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Iniziato | TD Cowen | Outperform |
| 2023-09-29 | Iniziato | William Blair | Outperform |
| 2023-03-08 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-11-30 | Iniziato | SVB Leerink | Outperform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-05-09 | Iniziato | B. Riley Securities | Buy |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2021-02-01 | Iniziato | SVB Leerink | Outperform |
| 2020-06-29 | Ripresa | Jefferies | Buy |
| 2019-08-16 | Aggiornamento | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Reiterato | RBC Capital Mkts | Outperform |
| 2016-09-23 | Ripresa | Credit Suisse | Neutral |
| 2016-02-24 | Reiterato | RBC Capital Mkts | Outperform |
| 2015-12-11 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Iniziato | Credit Suisse | Outperform |
| 2015-07-20 | Iniziato | Jefferies | Buy |
| 2015-07-20 | Iniziato | RBC Capital Mkts | Outperform |
| 2015-07-20 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-20 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Lantheus Holdings Inc Borsa (LNTH) Ultime notizie
B. Riley Adjusts Lantheus Holdings Price Target to $127 From $146, Maintains Buy Rating - Marketscreener.com
Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Q4 Earnings Alert: Lantheus Set to Unveil Critical 2024 Performance Data - StockTitan
William Blair Issues Positive Estimate for Lantheus Earnings - Defense World
Lantheus Holdings validates Fair Value model with 59% return since January 2024 - Investing.com India
Trend Tracker for (LNTH) - Stock Traders Daily
Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL
Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting - The Bakersfield Californian
Revolutionary Prostate Cancer Detection Breakthrough: Lantheus PYLARIFY Shows Success in Low PSA Patients - StockTitan
Blue Trust Inc. Boosts Stake in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Here's Why You Should Add Lantheus (LNTH) to Your Portfolio - MSN
Lantheus Holdings, Inc. (LNTH): Among the Best Low Risk High Growth Stocks To Invest In Now - Insider Monkey
Lantheus goes Evergreen in a $250m upfront deal - BioProcess Insider
12 Best Low Risk High Growth Stocks to Invest In - Insider Monkey
KBC Group NV Has $264,000 Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Janney Montgomery Scott LLC Acquires 5,753 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Janney Montgomery Scott LLC Grows Position in Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Position Increased by Swedbank AB - MarketBeat
SkyOak Wealth LLC Buys 5,000 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - MarketBeat
Lantheus (NASDAQ:LNTH) Releases FY 2024 Earnings Guidance - MarketBeat
LNTHLantheus Holdings, Inc Latest Stock News & Market Updates - StockTitan
Lantheus Appoints Dr. Morrow to Board of Directors - TipRanks
Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - MSN
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., to Board - citybiz
Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member - The Manila Times
Takeda's Oncology Chief Joins Lantheus Board: Major Win for Radiopharmaceutical Pipeline - StockTitan
Lantheus Holdings, Inc. Enters Agreement to Acquire Evergreen TheragnosticsOn January 27, 2025, Lantheus Holdings, Inc. (NASDAQ: LNTH) announced that its subsidiary, Lantheus Medical Imaging, Inc., has entered into a definitive Agreement and Plan of - Defense World
LNTH: Evergreen Acquisition Promotes Future Innovation - Research Tree
Lantheus expands in neuro and oncology with LMI and Evergreen acquisitions - Medical Device Network
Lantheus to acquire Evergreen Theragnostics for up to $1 billion - DOTmed
Lantheus (LNTH) Stock Declines Amid Acquisition Announcement - GuruFocus.com
Lantheus Holdings Inc. Announces Strategic Acquisition of Evergr - GuruFocus.com
Lantheus to Acquire Evergreen Theragnostics for $250 Million - MSN
Items Tagged with 'Life Molecular Imaging Ltd.' - BioWorld Online
Lantheus lights up market with $1.025B Evergreen buy - BioWorld Online
Lantheus to Acquire Evergreen Theragnostics to Expand Radiopharmaceutical Capabilities - HIT Consultant
Lantheus to buy radiopharma CDMO Evergreen Theragnostics for $250M upfront - MM+M Online
Lantheus to acquire Evergreen Theragnostics - MSN
Lantheus to Acquire Evergreen Theragnostics in $1B Deal - USA Herald
Lantheus (NASDAQ:LNTH) Trading Down 5.5%Should You Sell? - MarketBeat
4 Firms Look To Build $1B Sale Of Evergreen Theragnostics - Law360
Lantheus is on a buying spree. Its latest deal is worth up to $1B - The Business Journals
Lantheus lights up market with up to $1B Evergreen buy - BioWorld Online
Lantheus To Buy Evergreen Theragnostics For Over $1 Billion To Bolster Its Cancer Radiopharmaceutical Portfolio - Benzinga
Lantheus Holdings to Acquire Evergreen Theragnostics - Contract Pharma
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment - GuruFocus.com
Lantheus Holdings to Acquire Evergreen Theragnostics in All-Cash Transaction -January 28, 2025 at 06:52 am EST - Marketscreener.com
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader - PR Newswire
Lantheus to Acquire Evergreen Theragnostics for Upfront - GlobeNewswire
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive ... - The Bakersfield Californian
Major Radiopharmaceutical Deal: Lantheus's $1B Game-Changing Move Into Cancer Treatment Manufacturing - StockTitan
Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):